Print
Email
Vertex Pharmaceuticals Inc. has a market cap of $7.84 billion; its shares were traded at around $37.04 with and P/S ratio of 5.6. Vertex Pharmaceuticals Inc. had an annual average earning growth of 13.3% over the past 10 years.
CFO Recent Trades:
- EVP & CFO Ian F Smith sold 6,042 shares of VRTX stock on 01/19/2012 at the average price of 37. Ian F Smith owns at least 26,659 shares after this. The price of the stock has increased by 0.11% since.
This is the insider trade history vs. stock price of VRTX. For the complete insider trading history of VRTX, click here.
Directors and Officers Recent Trades:
- SVP, Human Resources Lisa Kelly sold 10,166 shares of VRTX stock on 01/19/2012 at the average price of 37. Lisa Kelly owns at least 28,209 shares after this. The price of the stock has increased by 0.11% since.
- SVP, Corp Affairs & Pub Policy Amit Sachdev sold 4,066 shares of VRTX stock on 01/19/2012 at the average price of 37. Amit Sachdev owns at least 35,626 shares after this. The price of the stock has increased by 0.11% since.
- EVP, Chief Commercial Officer Nancy Wysenski sold 6,042 shares of VRTX stock on 01/19/2012 at the average price of 37. Nancy Wysenski owns at least 21,893 shares after this. The price of the stock has increased by 0.11% since.
- EVP, Chief Commercial Officer Nancy Wysenski sold 5,000 shares of VRTX stock on 12/12/2011 at the average price of 28.9. Nancy Wysenski owns at least 27,935 shares after this. The price of the stock has increased by 28.17% since.
- Director Joshua S Boger sold 4,946 shares of VRTX stock on 12/01/2011 at the average price of 29.23. Joshua S Boger owns at least 740,681 shares after this. The price of the stock has increased by 26.72% since.
For the complete insider trading history of VRTX, click here.
Subscribe RSS
